News

Belgrade, Serbia 17 March 2022 –– Zdravlje A.D. (Zdravlje) announces the signing of a license agreement with the Medicines Patent Pool (MPP) for a generic version of nirmatrelvir, the novel oral COVID-19 antiviral medicine (PF-07321332) developed by Pfizer, which is administered in combination with low dose ritonavir (PF-07321332; ritonavir). This […]

Zdravlje is pleased to announce that as of 7 March 2022, Radmila Jakovljevic has joined our team as a Supply and Business Development Manager. Radmila will report directly to Dragan Cirkovic, Commercial Director. Radmila graduated from the Faculty of Agriculture at the University in Belgrade, and has a Master degree […]

Zdravlje is pleased to announce that as of 7 March 2022, Ms. Tamara Vasojevic has joined our senior management team as Group Human Resources Director, directly reporting to Kiren Naidoo (CEO). Tamara graduated from the Faculty of Philosophy in Belgrade, majoring in Adult Education, with additional education and development in […]

On the occasion of the Rare Disease World Day, 28 February, Zdravlje is sharing the general public information to help raise the awareness and generate the change for the 300 million people worldwide living with a rare disease, their families and carers.   What is a rare disease? A disease […]

Zdravlje is pleased to announce an important expansion of our commercial capabilities in Serbia. As of 10 January, Zdravlje has added five medical representatives who will be working directly with doctors and pharmacists to provide professional support, expertise and information on our high quality product portfolio. Our medical representatives will […]

Zdravlje is pleased to announce that as of 1 January 2022, Mr. Semir Attar has joined our senior management team as Director of Regulatory & Public Affairs, directly reporting to Kiren Naidoo (CEO). Semir brings over 20 years of valuable pharmaceutical industry experience across Regulatory, Public Affairs, Market Access and […]

    Zdravlje Leskovac continues its several-years’ activity aimed to support persons with disabilities as a partner to the “Cap for Handicap” Association. During the previous years since the beginning of this socially responsible activity, the caps that were collected with great dedication by employees of Zdravlje and its partners […]

Zdravlje is pleased to announce that as of 1st November 2021, Dragana Mirkovic has joined our team as a Product Manager. Dragana will report directly to Dragan Cirkovic, Commercial Director. Dragana graduated as a Doctor of Medicine from the University in Belgrade, specialising in Paediatrics. She brings valuable experience gained […]

Zdravlje announces signing of agreement with Celltrion Healthcare, a leading global biopharmaceutical company, for regional product rights to regdanvimab (CT-P59), a monoclonal antibody treatment for COVID-19 Regdanvimab (CT-P59) significantly reduced the risk of COVID-19 related hospitalisation or death by 72% for patients at high-risk of progressing to severe COVID-19 and […]

Zdravlje is pleased to announce that as of 11 October 2021, Ana Kostadinovic has joined our team in Belgrade as Office Manager, directly reporting to Chief Executive Officer Kiren Naidoo. Ana graduated Philology from the University of Belgrade and has built her career at renowned publishing, logistic and supply chain […]